entity

PARKINSON'S_DISEASE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARKINSON'S_DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

25Connections

19Hypotheses

14Analyses

0Outgoing

25Incoming

1Experiments

20Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (25)

Source	Relation	Type	Str
ASK1	associated_with	protein	0.90
alpha_synuclein_aggregation	causes	phenotype	0.90
GBA mutations	increases_risk	gene	0.90
GBA mutations	associated_with	gene	0.90
VPS35 mutations	causes	gene	0.90
alpha_synuclein	causes	protein	0.90
GCase	implicated_in	protein	0.90
alpha_synuclein	associated_with	protein	0.90
NNMT	implicated_in	gene	0.80
PARTICULATE_MATTER	causes	compound	0.80
GLUCOSE_METABOLISM	implicated_in	process	0.80
ALDH1A1+ dopaminergic neurons	associated_with	cell_type	0.70
alpha-synuclein pathway modulation	targets	pathway	0.70
alpha-synuclein pathway	regulates	pathway	0.70
GBA	associated_with	gene	0.70
Impaired Mitophagy	associated_with	phenotype	0.70
RGS6	decreases_risk	gene	0.70
Prevotellaceae	associated_with	gene	0.70
microbiome_alteration	associated_with	phenotype	0.70
neuroinflammation	associated_with	phenotype	0.70
Trpml1	targets	protein	0.70
Eliglustat	targets	drug	0.70
RGS6	targets	gene	0.70
truncal vagotomy	decreases_risk	gene	0.50
Gut Microbiome Dysbiosis	increases_risk	phenotype	0.50

Targeting Hypotheses (19)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
LRRK2 G2019S Kinase Inhibition for Parkinson's Disease	0.795	neurodegeneration	Test
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A	0.790	neurodegeneration	epigenetic reprogramming aging neurons
GBA1/GCase restoration to reduce alpha-synuclein pathology i	0.760	neurodegeneration	Test
LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein	0.745	neurodegeneration	Test
NLRP3 Inflammasome Inhibition for Neuroprotection in Parkins	0.720	neurodegeneration	Test

Pharmacologic activation of GBA1 to reduce alpha-synuclein b	0.720	neurodegeneration	Test
LRRK2 kinase inhibition to normalize lysosomal trafficking i	0.710	neurodegeneration	Test
Dasatinib plus Quercetin Senolytic Clearance of p16Ink4a-Hig	0.680	neurodegeneration	-
Mitophagy and NAD pathway enhancement in sporadic Parkinson'	0.670	neurodegeneration	Test
LRRK2 Haploinsufficiency Traps Microglia in Senescence-Like	0.650	parkinsons	-
Chronic ISR Activation Represses Axonal Protein Synthesis in	0.650	parkinsons	-
PINK1/Parkin-pathway mitophagy impairment in sporadic Parkin	0.630	neurodegeneration	Test
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia	0.610	neuroinflammation	How do regional, age, and sex-dependent
Exosomal α-Synuclein as an Interneuronal Propagation Vector	0.595	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Mitophagy Induction as Neuroprotective Strategy in Sporadic	0.585	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's	0.393	neurodegeneration	Test
TFEB Activation to Restore Lysosomal Function in Parkinson's	0.380	proteomics	Quantitative proteomics of the aging syn
TFEB Activation to Restore Lysosomal Biogenesis in Parkinson	0.380	proteomics	Quantitative proteomics of the aging syn
Multi-Clock Ensemble Discordance as a Parkinson's Disease Pr	0.323	-	Epigenetic clocks as biomarkers for Alzh

Mentioning Analyses (14)

Scientific analyses that reference this entity

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-25 | 5 hypotheses Top: 0.530

Gut Microbiome Analysis in Parkinson's Disease

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.778

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.575

Experiments (1)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Epigenetic clocks association with brain aging patterns in older women	exploratory	cognitive impairment and demen	0.900	0.00	human patients	proposed	N/A

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018

Debates (20)

Multi-agent debates referencing this entity

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

closed · Rounds: 4 · Score: 0.54 · 2026-04-25

This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

How does the gut microbiome composition differ between PD patients and healthy c

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The debate revealed conflicting evidence about whether TRPML1 activation rescues

closed · Rounds: 4 · Score: 0.72 · 2026-04-21

Related Research

Hypotheses and analyses mentioning PARKINSON'S_DISEASE in their description or question text

Pharmacologic activation of GBA1 to reduce alpha-synuclein burden in Parkinson's

Score: 0.720 · neurodegeneration · 2026-05-01

GBA1 mutations represent the strongest genetic risk factor for PD (OR 5-20x), and GCase dysfunction creates a druggable

LRRK2 kinase inhibition to normalize lysosomal trafficking in Parkinson's diseas

Score: 0.710 · neurodegeneration · 2026-05-01

LRRK2 G2019S mutations cause autosomal dominant PD through hyperactivation that impairs vesicular trafficking via Rab GT

Mitophagy and NAD pathway enhancement in sporadic Parkinson's disease

Score: 0.670 · neurodegeneration · 2026-04-29

Sporadic Parkinson's disease may involve impaired mitochondrial quality control, and NAD augmentation or other mitophagy

PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease

Score: 0.630 · neurodegeneration · 2026-04-30

Sporadic PD may include impaired mitochondrial quality control, reduced mitophagy flux, and dopaminergic vulnerability o

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Score: 0.610 · neuroinflammation · 2026-04-22

## Mechanistic Overview Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Disease Pathology s

Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disea

Score: 0.595 · neurodegeneration · 2026-04-26

Misfolded α-synuclein aggregates are transmitted via exosomes from donor to recipient neurons, templating endogenous aSy

Mitophagy Induction as Neuroprotective Strategy in Sporadic Parkinson's Disease

Score: 0.585 · neurodegeneration · 2026-04-26

PINK1/PARKIN-mediated mitophagy is impaired in sporadic PD due to upstream mitochondrial stress. Enhancing parkin transl

USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's Disease

Score: 0.393 · neurodegeneration · 2026-05-06

USP13 deubiquitinates and stabilizes PINK1 and Parkin, enhancing mitophagy. USP13 downregulation in sporadic PD brains l

TFEB Activation to Restore Lysosomal Function in Parkinson's Disease Alpha-Synuc

Score: 0.380 · proteomics · 2026-04-27

Parkinson's disease is characterized by the accumulation of misfolded alpha-synuclein protein aggregates (Lewy bodies) i

TFEB Activation to Restore Lysosomal Biogenesis in Parkinson's Disease Dopaminer

Score: 0.380 · proteomics · 2026-04-27

Age-related decline in lysosomal function contributes to the accumulation of pathological protein aggregates in Parkinso

Multi-Clock Ensemble Discordance as a Parkinson's Disease Prodrome Detector — Ep

Score: 0.323 · unknown disease · 2026-04-25

Concise Statement: In Parkinson's disease, different epigenetic clock algorithms (Horvath, Hannum, PhenoAge, GrimAge) g

PARKINSON'S_DISEASE

Understanding Entity Pages

Outgoing (0)

Incoming (25)

Targeting Hypotheses (19)

Mentioning Analyses (14)

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

Gut Microbiome Analysis in Parkinson's Disease

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

Why does PGC-1α overexpression paradoxically increase MPTP toxicity despite enha

Does reduced Prevotellaceae abundance cause PD pathology or result from it?

Do transferred mitochondria from diseased astrocytes carry pathological damage t

What is the therapeutic window between GCS inhibition efficacy and systemic toxi

GBA-Synuclein Loop Therapeutics for PD

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

Experiments (1)

Related Papers (5)

Debates (20)

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis

Can computational de novo protein binder design produce stable binders that bloc

How does the gut microbiome composition differ between PD patients and healthy c

The debate revealed conflicting evidence about whether TRPML1 activation rescues

Related Research

Pharmacologic activation of GBA1 to reduce alpha-synuclein burden in Parkinson's

LRRK2 kinase inhibition to normalize lysosomal trafficking in Parkinson's diseas

Mitophagy and NAD pathway enhancement in sporadic Parkinson's disease

PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disea

Mitophagy Induction as Neuroprotective Strategy in Sporadic Parkinson's Disease

USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's Disease

TFEB Activation to Restore Lysosomal Function in Parkinson's Disease Alpha-Synuc

TFEB Activation to Restore Lysosomal Biogenesis in Parkinson's Disease Dopaminer

Multi-Clock Ensemble Discordance as a Parkinson's Disease Prodrome Detector — Ep